Resources

Severe opioid withdrawal, risk of patient-initiated discharge, and some inpatients’ use of unregulated substances prompt clinical and ethical questions considered in this commentary on a case.&nbsp

This article describes the implementation and evaluation of four Safer Opioid Supply programs (SSPs) in Ontario, one in London and three in Toronto.

This is a commentary on the author's recent study: Hippocampal volume loss in individuals with a history of non-fatal opioid overdose

This report summarizes the literature on ketamine as a treatment for adults with substance use disorders.

This paper discusses how fentanyl and the toxic drug supply complicates hospital Opioid Use Disorder (OUD) care. 

To ensure optimal management of opioid use disorder (OUD), the updated 2024 CRISM National Guideline incorporates recent research, clinical insights, and input from individuals with lived experienc

This paper describes a novel, volunteer physician-led interprofessional approach to identifying patients with opioid use disorder (OUD), initiating buprenorphine, and linking to office-based opioid

Is coprescription of hydromorphone tablets or sustained-release oral morphine (opioid risk mitigation guidance [RMG]) and opioid agonist treatment (OAT) associated with subsequent OAT receipt?

We provide a synopsis of the 2024 update of the 2018 National Guideline for the Clinical Management of Opioid Use Disorder, from the Canadian Research Initiative in Substance Matters (CRISM).

To assess the risk of treatment discontinuation and mortality among individuals receiving buprenorphine/naloxone vs methadone for the treatment of opioid use disorder.

The scope of the Publicly Available Specification (PAS) focuses on health-care providers who are able to prescribe medications in Canada with specific emphasis on prescribers who do not consider th

Sublingual buprenorphine is most commonly available in co-formulation with naloxone.

Disturbances in emotion regulation among people who use opioids receiving methadone maintenance treatment (MMT) was reported in a few small studies.